Mark Klempner to Clindamycin
This is a "connection" page, showing publications Mark Klempner has written about Clindamycin.
Connection Strength
0.366
-
Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy. JAMA. 1988 Nov 11; 260(18):2682-5.
Score: 0.077
-
Styrt B, Klempner MS. Lysosomotropic amines modulate neutrophil calcium homeostasis. J Cell Physiol. 1988 May; 135(2):309-16.
Score: 0.075
-
Ho JL, Klempner MS. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus. Diagn Microbiol Infect Dis. 1986 Feb; 4(2):133-8.
Score: 0.064
-
Klempner MS, Styrt B. Alkalinization of the intralysosomal pH by clindamycin and its effects on neutrophil function. J Antimicrob Chemother. 1983 Oct; 12 Suppl C:39-50.
Score: 0.054
-
Klempner MS, Styrt B. Clindamycin uptake by human neutrophils. J Infect Dis. 1981 Nov; 144(5):472-9.
Score: 0.048
-
Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis. 1996 May; 22(5):809-12.
Score: 0.032
-
Styrt B, Klempner MS. Inhibition of neutrophil oxidative metabolism by lysosomotropic weak bases. Blood. 1986 Feb; 67(2):334-42.
Score: 0.016